Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia

Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia

Direct leukemic infiltration of the eye is most frequently associated with acute lymphoblastic leukemia (ALL), probably due to its well-known central nervous system (CNS) tropism. Systemic treatment alone may not be sufficient for intraocular leukemia. Data on local treatment are scarce. Here, we pr...

Full description

Bibliographic Details
Main Authors:	Matteo Pederzolli, Fabio Giglio, Maria Vittoria Cicinelli, Alessandro Marchese, Giulio Modorati, Sara Mastaglio, Fabio Ciceri, Francesco Bandello, Elisabetta Miserocchi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Oncology
Subjects:	intraocular leukemia methotrexate acute lymphoblastic leukemia intravitreal injections case report intravitreal methotrexate
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.951362/full

Similar Items

Intravitreal methotrexate in type B lymphoblastic leukemia—Case Report
by: Maria Isabel Maya Naranjo, et al.
Published: (2023-08-01)

Clinical outcomes of intravitreal methotrexate injection protocol with a reduced initial frequency for intraocular lymphoma
by: Chiung-Ju Hsu, et al.
Published: (2022-01-01)

Intravitreal Methotrexate
by: Fatemeh Abdi, et al.
Published: (2021-10-01)

Tolerability and Efficacy of Multiple Series of Intravitreal Methotrexate Injections for Complex Retinal Detachment Associated with Proliferative Vitreoretinopathy
by: Tessnim R. Ahmad, et al.
Published: (2023-04-01)

Management of noninfectious posterior uveitis with intravitreal drug therapy
by: Tan HY, et al.
Published: (2016-10-01)

Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
by: Tingting Jiang, et al.
Published: (2022-09-01)

Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity
by: Marjan Abedi, et al.
Published: (2020-05-01)

Effect of methotrexate and doxorubicin cumulative doses on superoxide dismutase levels in childhood acute lymphoblastic leukemia
by: Khalida Fetriyani Ningsih, et al.
Published: (2015-10-01)

Methotrexate-Mediated Arachnoiditis in a Child with Acute Lymphoblastic Leukemia
by: Sırma Karamercan, et al.
Published: (2022-11-01)

Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis
by: Jong G. Park, et al.
Published: (2020-09-01)

Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
by: Ning Xin, et al.
Published: (2019-09-01)

Electrophysiological Monitoring of Focal and Entire Retinal Function during Treatment with Intravitreal Methotrexate for Intraocular Lymphoma
by: Takashi Matsushima, et al.
Published: (2021-04-01)

Vitrectomy with Silicone Oil Tamponade and Single-Dose Intravitreal Methotrexate for Recurrent Retinal Detachment with Proliferative Vitreoretinopathy
by: Adrian Babel, et al.
Published: (2022-10-01)

Recurrence of methotrexate-induced leukoencephalopathy after methotrexate rechallenge: A case report and literature review
by: Ammar AlKawi, MD, et al.
Published: (2023-03-01)

Identifying risk factors for high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia
by: Li X, et al.
Published: (2019-07-01)

Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia
by: Vasiliki Karpa, et al.
Published: (2023-11-01)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
by: Xuan Gao, et al.
Published: (2021-07-01)

Predicting delayed methotrexate elimination in pediatric acute lymphoblastic leukemia patients: an innovative web-based machine learning tool developed through a multicenter, retrospective analysis
by: Chang Jian, et al.
Published: (2023-08-01)

Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies
by: Zachary L. Taylor, et al.
Published: (2021-06-01)

Higher incidence of delayed methotrexate clearance in pediatric acute lymphoblastic leukemia patients treated with imatinib
by: Inge M. van der Sluis, et al.
Published: (2023-12-01)

Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia
by: Meng Xu, et al.
Published: (2022-11-01)

Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate
by: Magdalena Cwiklinska, et al.
Published: (2020-06-01)

Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines
by: Rafael Renatino Canevarolo, et al.
Published: (2022-12-01)

The influence of detoxification agents on the intensity of side effects caused by medium-high doses of methotrexate in children with acute lymphoblastic leukemia: Case series
by: Šumar Jovana S., et al.
Published: (2014-01-01)

Erratum: Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines
by: Frontiers Production Office
Published: (2023-03-01)

Retrospective evaluation and prediction of clearance and toxicity of high dose methotrexate in childhood acute lymphoblastic leukemia patients
by: Yuxia Shan, et al.
Published: (2021-04-01)

Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia
by: Min Zhan, et al.
Published: (2023-06-01)

Effects of aqueous extract of catechin tea on some parameters of sperms and histopathological changes in testis of mice treated with Methotrexate (MTX)
by: Abbas Fadhil Daham, et al.
Published: (2010-12-01)

High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia
by: Yazhi Zhang, et al.
Published: (2020-06-01)

Serous Retinal Detachments Complicating Interferon-α and Ribavirin Treatment in Patients with Hepatitis C
by: Giulio Modorati, et al.
Published: (2011-03-01)

Utility of repeated drug level measurements after high dose methotrexate infusion for treatment planning in pediatric leukemia
by: Terzi Özlem, et al.
Published: (2022-12-01)

Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging
by: Kushal Delhiwala
Published: (2022-01-01)

Is hypoalbuminemia a risk factor for high-dose methotrexate toxicity in children with acute lymphoblastic leukemia?
by: Shaimaa Barakat, et al.
Published: (2022-04-01)

Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single‐center real‐world clinical experience
by: Gi‐June Min, et al.
Published: (2023-04-01)

The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment
by: Shoshana Rudin, et al.
Published: (2017-04-01)

New insights into methotrexate accumulation in leukemia cells in vivo
by: Elixabet Lopez-Lopez, et al.
Published: (2021-01-01)

10.4274/tjo.91249
by: Osman Okan Olcaysü, et al.
Published: (2014-05-01)

HLA-A29-Positive Uveitis: Birdshot Chorioretinopathy, What Else
by: Ilaria Zucchiatti, et al.
Published: (2013-12-01)

Methotrexate-Induced Subacute Combined Degeneration in Acute Lymphoblastic Leukemia with CNS Relapse May Be Reversible
by: David Bared Dukenik, et al.
Published: (2023-10-01)

Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0–45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol
by: Linea Natalie Toksvang, et al.
Published: (2022-05-01)